Baxter recalled its IV solutions due to potential health risks

Baxter International Incorporated has voluntarily issued a product recall of four lots of 0.9% sodium chloride injection and one lot of 5% dextrose injection on December 27 after learning of the presence of particulate matter in its intravenous (IV) solutions.

John O’Malley of Baxter said the recalled lots constitute about 795,000 individual units. The recalled units have been distributed in the United States and in other countries such as Singapore and Saudi Arabia from May 2012 to October 2013.

Particulate matter in IV solutions may cause obstruction of blood vessels, potentially leading to serious medical complications such as heart attack, stroke, and organ damage.

If you have experienced physical or financial harm due to a defective product, learn more about your rights and options under the law by speaking with an Atlanta attorney from Ausband & Dumont. Call us at (404) 812-0051 today for a free case assessment.